• Publications
  • Influence
2011 update of the drug resistance mutations in HIV-1.
This November 2011 edition of the IAS-USA drug resistance mutations list updates the figures last published in December 2010 (Johnson VA et al, Top HIV Med, 2010;18:156-163).
  • 337
  • 38
  • PDF
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
BACKGROUND Highly active antiretroviral therapy (HAART) decreases viral load and increases CD4 T-cell counts in patients with advanced HIV-1 infection. Whether HAART can improve CD4 T-cell function,Expand
  • 550
  • 15
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of
During ZDV or d4T exposure, mutations at codons 41, 67, 70, 210, 215, and 219 can be selected and were named thymidine analogue mutations (TAMs). Some previous results suggested that different TAMsExpand
  • 120
  • 14
Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
ABSTRACT Raltegravir (MK-0518) is a potent inhibitor of human immunodeficiency virus (HIV) integrase and is clinically effective against viruses resistant to other classes of antiretroviral agents.Expand
  • 284
  • 13
2015 Update of the Drug Resistance Mutations in HIV-1.
The 2015 edition of the IAS-USA drug resistance mutations list updates the figures last published in July 2014. The mutations listed are those that have been identified by specific criteria forExpand
  • 140
  • 13
Volume effects in the Keller-Segel model : energy estimates preventing blow-up
Abstract We obtain a priori estimates for the classical chemotaxis model of Patlak, Keller and Segel when a nonlinear diffusion or a nonlinear chemosensitivity is considered accounting for the finiteExpand
  • 175
  • 12
  • PDF
The parabolic-parabolic Keller-Segel model in R2
Abstract. This paper is devoted mainly to the global existence problem for the two-dimensional parabolic-parabolic Keller-Segel system in the full space. We derive a critical mass threshold belowExpand
  • 133
  • 12
  • PDF
A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy
Purpose: To develop a tumor growth inhibition model for adult diffuse low-grade gliomas (LGG) able to describe tumor size evolution in patients treated with chemotherapy or radiotherapy. ExperimentalExpand
  • 96
  • 10
  • PDF
Convergence of the Mass-Transport Steepest Descent Scheme for the Subcritical Patlak-Keller-Segel Model
Variational steepest descent approximation schemes for the modified Patlak-Keller-Segel equation with a logarithmic interaction kernel in any dimension are considered. We prove the convergence of theExpand
  • 186
  • 10
  • PDF
Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients
ABSTRACT The aim of the present study was to assess the pharmacokinetic behavior of atazanavir-ritonavir when it is coadministered with tenofovir disoproxil fumarate (DF) in human immunodeficiencyExpand
  • 215
  • 9
  • PDF